Taurochenodeoxycholic acid ameliorates the Staphylococcus aureus infection-induced acute lung injury through toll-like receptor 2 in mice
International Immunopharmacology · 2024
DOI: 10.1016/j.intimp.2024.113228 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Zhiguo Gong und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Clinical Diagnosis and Treatment Techniques for Animal Disease, Ministry of Agriculture, Inner Mongolia Agricultural University, No…. Hauptthemen laut MEDLINE: Toll-Like Receptor 2, Acute Lung Injury, Staphylococcus aureus, Staphylococcal Infections. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 70 Literaturangaben. Gefördert von: Government of Inner Mongolia Autonomous Region, National Natural Science Foundation of China.
Abstract (Originalsprache)
Acute lung injury (ALI) is a significant clinical problem associated with high morbidity and mortality. Inflammation induced by gram-positive bacterial pathogens, specifically Staphylococcus aureus (S. aureus), plays a major role in ALI development and other infectious diseases. Taurochenodeoxycholic acid (TCDCA) exhibits diverse biological activities and pharmacological effects. Nevertheless, the potential preventive and therapeutic effects of TCDCA and the underlying mechanism in the ALI induced by S. aureus infection remain poorly understood. Our results showed that the TCDCA (0.1 μg/g) had a beneficial effect on lung damage in mice infected with S. aureus. Specifically, TCDCA could lead to a reduction in pulmonary focal or diffuse oedema and a decrease in the infiltration of neutrophils in the S. aureus-infected lungs. We observed that TCDCA could significantly down-regulate the expression of HMGB1 in lung from S. aureus-infected mice. Furthermore, TCDCA could attenuate the production of inflammatory mediators in lungs and serum from S. aureus-infected mice. This finding further supported the notion that TCDCA potentially protects against tissue injury. In addition, TCDCA regulated the secretion of the proinflammatory cytokine, the activation of MAPK and NF-κB signaling pathways, and the activation of TLR2 in macrophages. Notably, TCDCA might reduce the secretion levels of inflammatory mediators and lung damage through the TLR2 in S. aureus-infected macrophages or mice. Altogether, TCDCA shows promise as a potential drug for preventing and treating ALI by modulating or inhibiting inflammatory mediators through TLR2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Clinical Diagnosis and Treatment Techniques for Animal Disease, Ministry of Agriculture, Inner Mongolia Agricultural University, No. 29, Erdosdong Road, Saihan District, 010011, Hohhot, China; Laborato…
Förderung
- Government of Inner Mongolia Autonomous Region
- National Natural Science Foundation of China
Zitieren
APA
Gong, Z., Mao, W., Ren, P., Hao, Z., Zhao, J., Yu, Z., Zhao, Y., Feng, Y., Liu, B., & Zhang, S. (2024). Taurochenodeoxycholic acid ameliorates the Staphylococcus aureus infection-induced acute lung injury through toll-like receptor 2 in mice. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.113228
Vancouver
Gong Z, Mao W, Ren P, Hao Z, Zhao J, Yu Z, et al. Taurochenodeoxycholic acid ameliorates the Staphylococcus aureus infection-induced acute lung injury through toll-like receptor 2 in mice. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.113228
BibTeX
@article{Gong2024,
author = {Gong, Zhiguo and Mao, Wei and Ren, Peipei and Hao, Zhichao and Zhao, Jiamin and Yu, Zhuoya and Zhao, Yi and Feng, Yaya and Liu, Bo and Zhang, Shuangyi},
title = {Taurochenodeoxycholic acid ameliorates the Staphylococcus aureus infection-induced acute lung injury through toll-like receptor 2 in mice},
journal = {International Immunopharmacology},
year = {2024},
doi = {10.1016/j.intimp.2024.113228}
}
EUVIMED